Press Releases | Medtronic

Month Year

Email alerts

Oct 13, 2014

Covidien Promotes Greater Global Awareness of Thrombosis Risks

Covidien Promotes Greater Global Awareness of Thrombosis Risks

October 13, 2014 12:01 AM Eastern Daylight Time DUBLIN, Ireland--(BUSINESS WIRE)--As part of a global effort to highlight the threat posed by venous thromboembolism (VTE), Covidien plc today...
Oct 10, 2014

Covidien Initiates Voluntary Field Safety Alert for Medi-Trace™ Cadence and Kendall™ Multi-function Defibrillation Electrodes

Dublin, Ireland -- October 10, 2014 – Covidien today announced that it has notified customers of a voluntary Field Safety Alert for certain Medi-Trace™ Cadence and Kendall™ Multi-function...
Oct 10, 2014

Medtronic Announces Executive Leadership Team for Combined Organization Upon Close of Covidien Acquisition

MINNEAPOLIS -- October 10, 2014 -- Medtronic (NYSE: MDT) today announced the executive team who will lead the combined organization following the close of its proposed acquisition of Covidien. The...
Oct 10, 2014

Announcement under Irish Takeover Rules Relevant Securities in Issue – October 10, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 10, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
Oct 9, 2014

Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for Nellcor™ Portable SpO2 Patient Monitoring System

Monitor is only portable oximeter on the market that is indicated for use in home care settings and is compliant with international standards for devices used in the home health care environment

DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 9, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the Nellcor™ Portable SpO2 Patient Monitoring...
Oct 8, 2014

Form 8.1 – Covidien

DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 8, 2014-- Covidien plc: FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
Oct 7, 2014

Announcement under Irish Takeover Rules Relevant Securities in Issue – October 7, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 7, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
Oct 7, 2014

New Evaluation System Leads to Incontinence Relief

FDA-Approved System Provides Patients with Added Benefits While Testing Innovative Therapy for Bladder and Bowel Incontinence

MINNEAPOLIS - October 7, 2014 - After living with overactive bladder and urinary retention symptoms for 11 years, Jennifer LaForest, a 26-year-old woman from Auburn Hills, Michigan, recently...
Oct 3, 2014

Medtronic Announces Updated Financing Plans for Covidien Acquisition

Company reaffirms commitment to Covidien transaction

MINNEAPOLIS -October 3, 2014- Medtronic, Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, today announced that it intends to use approximately $16 billion in...
Sep 30, 2014

Survey Shows 43 Percent of Americans Ages 40 and Older Have Experienced Symptoms of Peripheral Arterial Disease (PAD)

Despite prevalence of PAD symptoms, the majority of patients have not consulted a physician

DUBLIN, Ireland, Sep 30, 2014 (BUSINESS WIRE) --More than 40 percent of Americans aged 40 and older have experienced one or more of the most common symptomsi of peripheral arterial disease (PAD)....

Show per page